Beijing SL Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 548.43 million compared to CNY 617.66 million a year ago. Revenue was CNY 554.22 million compared to CNY 624.53 million a year ago.

Net income was CNY 165.33 million compared to CNY 301.54 million a year ago. Basic earnings per share from continuing operations was CNY 0.1609 compared to CNY 0.2935 a year ago. Diluted earnings per share from continuing operations was CNY 0.1609 compared to CNY 0.2935 a year ago.